NCT03380806 - Prostate Boost Irradiation With Stereotactic Body RT (SBRT) | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions

Prostate Cancer

Interventions

DRUG

LHRH agonist

Standard LHRH agonist for 3 years

RADIATION

Pelvic Radiation

RADIATION

Stereotactic Body Radiotherapy (SBRT)

SBRT: 19.5 - 21 Gy in three fractions (1 treatment per week - over 22days)

RADIATION

Conventional Radiotherapy (CRT) Prostate Boost

CRT: 33 - 35 Gy in 16 fractions (5 days per week - over 22 days)

Trial Locations (2)

RECRUITING

Juravinski Cancer Centre, Hamilton

RECRUITING

Walker Family Cancer Centre ,Niagara Health - St. Catharines Site, St. Catharines